Stay updated on BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page.

Latest updates to the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 is now displayed on the page, replacing v3.4.1, indicating a minor site update that does not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 with no impact on study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedUI changes include adding glossary toggle options (Show glossary / Hide glossary) and updating metadata labels and revision text (e.g., Last Update Submitted that Met QC Criteria vs. met QC Criteria, No FEAR Act Data) with a new Revision: v3.4.0; older labels were removed.SummaryDifference0.3%

- Check60 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page footer.SummaryDifference0.0%

- Check82 days agoChange DetectedAdded an expanded Locations section with state-specific study sites and updated the revision tag to v3.3.3. Removed the HHS Vulnerability Disclosure link and the prior v3.3.2 entry.SummaryDifference1%

Stay in the know with updates to BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page.